Work

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

Year: 1995

Type: article

Source: PubMed

Authors: C J Wikstrand, L P Hale, S K Batra, M L Hill, P A Humphrey, S N Kurpad, R E McLendon, D Moscatello, C N Pegram, C J Reist

Institutions: Duke Medical Center, Washington University in St. Louis, Thomas Jefferson University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: INTRATHECAL THERAPY OF MELANOMA NEOPLASTIC MENINGITIS, DIAGNOSIS AND NEW THERAPEUTICS IN SURGICAL ONCOLOGY

OpenAlex ID: W2159542715

FWCI: 6.314

Cites: 40

Cited by: 469

Related to: 10